BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24914203)

  • 1. Plasma levels of nitric oxide metabolites are markedly reduced in normotensive men with electrocardiographically determined left ventricular hypertrophy.
    Kamezaki F; Tsutsui M; Takahashi M; Sonoda S; Kubo T; Fujino Y; Adachi T; Abe H; Takeuchi M; Mayumi T; Otsuji Y
    Hypertension; 2014 Sep; 64(3):516-22. PubMed ID: 24914203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin level and left ventricular hypertrophy in Japanese men.
    Mitsuhashi H; Yatsuya H; Tamakoshi K; Matsushita K; Otsuka R; Wada K; Sugiura K; Takefuji S; Hotta Y; Kondo T; Murohara T; Toyoshima H
    Hypertension; 2007 Jun; 49(6):1448-54. PubMed ID: 17420337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography.
    Petersen SS; Pedersen LR; Pareek M; Nielsen ML; Diederichsen SZ; Leósdóttir M; Nilsson PM; Diederichsen AC; Olsen MH
    Blood Press; 2017 Feb; 26(1):54-63. PubMed ID: 27662908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A; Barrios V; Escobar C; Ferrer E; Barrios S; González-Pedel V; Montoro P; Navarro-Cid J
    Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Dahlof B;
    Circulation; 2003 Aug; 108(6):684-90. PubMed ID: 12885747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and ECG left ventricular hypertrophy.
    Muiesan ML; Salvetti M; Di Castelnuovo A; Paini A; Assanelli D; Costanzo S; Badilini F; Vaglio M; Donati MB; Agabiti Rosei E; de Gaetano G; Iacoviello L;
    J Hypertens; 2017 Jan; 35(1):162-169. PubMed ID: 27662187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A; Adebiyi AA; Aje A; Oladapo OO; Falase AO
    Ethn Dis; 2005; 15(4):578-84. PubMed ID: 16259479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease.
    van Kleef MEAM; Visseren FLJ; Vernooij JWP; Nathoe HM; Cramer MM; Bemelmans RHH; van der Graaf Y; Spiering W;
    J Hypertens; 2018 Sep; 36(9):1865-1873. PubMed ID: 29878973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of the ECG diagnosis of left ventricular hypertrophy in normotensive and moderately hypertensive men when using the echocardiographic assessment of left ventricular mass index as reference.
    Otterstad JE; Froeland G; Wasenius AK; Knutsen KM; Michelsen S; Stugaard M
    J Hum Hypertens; 1991 Apr; 5(2):101-6. PubMed ID: 1830106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI.
    Alfakih K; Walters K; Jones T; Ridgway J; Hall AS; Sivananthan M
    Hypertension; 2004 Aug; 44(2):175-9. PubMed ID: 15226274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECG left ventricular hypertrophy is a stronger risk factor for incident cardiovascular events in women than in men in the general population.
    Porthan K; Niiranen TJ; Varis J; Kantola I; Karanko H; Kähönen M; Nieminen MS; Salomaa V; Huikuri HV; Jula AM
    J Hypertens; 2015 Jun; 33(6):1284-90. PubMed ID: 25764049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study.
    Larstorp AC; Okin PM; Devereux RB; Olsen MH; Ibsen H; Dahlöf B; Kjeldsen SE; Wachtell K
    J Hum Hypertens; 2011 Mar; 25(3):178-85. PubMed ID: 20505749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and covariates of electrocardiographic left ventricular hypertrophy in diabetic patients in Tanzania.
    Lutale JJ; Thordarson H; Gulam-Abbas Z; Vetvik K; Gerdts E
    Cardiovasc J Afr; 2008; 19(1):8-14. PubMed ID: 18320079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment of echocardiographic left ventricular hypertrophy with electrocardiography, body mass index and blood pressure.
    Varis JP; Puukka PJ; Karanko HM; Jula AM
    Blood Press; 2014 Feb; 23(1):39-46. PubMed ID: 23772751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of ECG criteria for the diagnosis of left ventricular hypertrophy: a comparison with magnetic resonance imaging.
    Krittayaphong R; Nomsawadi V; Muenkaew M; Miniphan M; Yindeengam A; Udompunturak S
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S124-32. PubMed ID: 23590032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
    Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.